Mucinous carcinoma (non-intestinal type) arising in the ovarian mature cystic teratoma - a case report
![PDF) Utility of P63 immunohistochemical stain in differentiating urothelial carcinomas from adenocarcinomas of prostate PDF) Utility of P63 immunohistochemical stain in differentiating urothelial carcinomas from adenocarcinomas of prostate](https://i1.rgstatic.net/publication/50364242_Utility_of_P63_immunohistochemical_stain_in_differentiating_urothelial_carcinomas_from_adenocarcinomas_of_prostate/links/5ada36330f7e9b28593e57d5/largepreview.png)
PDF) Utility of P63 immunohistochemical stain in differentiating urothelial carcinomas from adenocarcinomas of prostate
![CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers | Breast Cancer Research | Full Text CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers | Breast Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13058-018-1076-x/MediaObjects/13058_2018_1076_Fig4_HTML.png)
CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers | Breast Cancer Research | Full Text
![CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers | Breast Cancer Research | Full Text CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers | Breast Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13058-018-1076-x/MediaObjects/13058_2018_1076_Fig1_HTML.png)